Venture Capital News: Coherence Neuro Brings in $45M Series A Funding
2026-10-26
Tweet
SAN FRANCISCO, CA, Coherence Neuro, a neurotechnology company developing implantable devices to monitor and potentially treat cancer, raised $45 million in Series A funding co-led by Founders Fund and the OpenAI Startup Fund.
Coherence Neuro, a neurotechnology company developing implantable devices to monitor and potentially treat cancer, raised $45 million in Series A funding co-led by Founders Fund and the OpenAI Startup Fund.
New investors included Lux Capital, 8VC, Timeless, Olive Capital and Ahren. Returning backers included Blackbird, Possible Ventures, Topology Ventures, Artesian, XEIA Venture Partners, Xtal and Divergent.
New investors included Lux Capital, 8VC, Timeless, Olive Capital and Ahren. Returning backers included Blackbird, Possible Ventures, Topology Ventures, Artesian, XEIA Venture Partners, Xtal and Divergent.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors
